Heart Failure
3,722
528
669
1,853
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
489 trials with published results (13%)
Research Maturity
1853 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.2%
230 terminated out of 3722 trials
89.0%
+2.5% vs benchmark
12%
451 trials in Phase 3/4
26%
489 of 1853 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1853 completed trials
Clinical Trials (3722)
ST2 for the Management of Heart Failure - STADE-HF
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
DANHEART (H-HeFT and Met-HeFT)
Optimization of Coronary Sinus Lead Placement for CRT Delivery in Non-LBBB or Narrow LBBB Patterns Using Multiparametric 82Rubidium PET-CT Scan Analysis and Cardiac CT Venography
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NORM-HF Pivotal Study
Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress: the Lift RCT
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart Failure and Postoperative Outcome in Surgery - a National Registry Study
The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients
Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure
The Fontan Dapagliflozin Pilot Study
Bedside Assessment of Right Ventricular Output Lying in Prone Or Supine Position
SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure
Physiological Effects Ketone Ester in Heart
Symptom Care at Home-Heart Failure
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
Digital Literacy of Chronic Heart Failure Patients